Mapping the functional assessment of cancer therapy-general or -colorectal to SF-6D in Chinese patients with colorectal neoplasm

Value in Health

Volumn 15, Issue 3, 2012, Pages 495-503

  Wong, Carlos K H ^a   Lam, Cindy L K ^a   Rowen, Donna ^b   McGhee, Sarah M ^a   Ma, Ka Ping ^a   Law, Wai Lun ^a   Poon, Jensen T C ^a   Chan, Pierre ^c   Kwong, Dora L W ^a   Tsang, Janice ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

colorectal neoplasm; FACT C; mapping; patient reported outcomes; quality of life; SF 6D

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; COLORECTAL TUMOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ECONOMIC EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY COLORECTAL; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS;

AGED; CHINA; COLORECTAL NEOPLASMS; FEMALE; HEALTH SURVEYS; HONG KONG; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; QUALITY OF LIFE; SELF REPORT;

EID: 84861174578     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.12.009     Document Type: Article

References (43)

1. Z.F. Gellad, D. Provenzale Colorectal cancer: national and international perspective on the burden of disease and public health impact Gastroenterology 138 2010 2177 2190
2. National Institute for Clinical Excellence Guide to the Methods of Technology Appraisal (reference N1618) 2008 National Institute for Clinical Excellence London
3. J. Brazier, M. Deverill, C. Green A review of the use of health status measures in economic evaluation Health Technol Assess 3 1999 23 56
4. T. Shiroiwa, T. Fukuda, K. Tsutani Health utility scores of colorectal cancer based on societal preference in Japan Qual Life Res 18 2009 1095 1103
5. J.H. Best, L.P. Garrison, W. Hollingworth Preference values associated with stage III colon cancer and adjuvant chemotherapy Qual Life Res 19 2010 391 400
6. D. Dobrez, D. Cella, A.S. Pickard Estimation of patient preference-based utility weights from the Functional Assessment of Cancer Therapy-General Value Health 10 2007 266 272 (Pubitemid 47077251)
7. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108 (Pubitemid 127453463)
8. J. Brazier, J. Roberts, M. Deverill The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 2002 271 292 (Pubitemid 34143147)
9. J.E. Brazier, J. Roberts The estimation of a preference-based measure of health from the SF-12 Med Care 42 2004 851 859 (Pubitemid 39456916)
10. J.E. Brazier, S. Fukuhara, J. Roberts Estimating a preference-based index from the Japanese SF-36 J Clin Epidemiol 62 2009 1323 1331
11. L.N. Ferreira, P.L. Ferreira, L.N. Pereira A Portuguese value set for the SF-6D Value Health 13 2010 624 630
12. C.L.K. Lam, J. Brazier, S.M. McGhee Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population Value Health 11 2008 295 303 (Pubitemid 351473610)
13. L.N. Cruz, S.A. Camey, J.F. Hoffmann Estimating the SF-6D value set for a population-based sample of Brazilians Value Health 14 Suppl. 2011 S108 S114
14. M.J. Buxton, L.A. Lacey, B.G. Feagan Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility Value Health 10 2007 214 220 (Pubitemid 46802279)
15. N. Kontodimopoulos, V.H. Aletras, D. Paliouras Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments Value Health 12 2009 1151 1157
16. S. Sauerland, S. Weiner, K. Dolezalova Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients Value Health 12 2009 364 370
17. J.E. Brazier, Y. Yang, A. Tsuchiya A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
18. Wong CKH, Lam CLK, Law WL, et al. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. J Eval Clin Pract. In press. DOI: 10.1111/j.1365-2753.2011.01753.x.
19. P. Franks, E.I. Lubetkin, M.R. Gold Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample Med Decis Making 24 2004 247 254 (Pubitemid 38656308)
20. E.Q. Wu, P. Mulani, H.F. Max Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients Value Health 10 2007 408 414 (Pubitemid 47481112)
21. R. Ara, J. Brazier Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available) Value Health 11 2008 1131 1143
22. W.S. Atkin, B.P. Saunders Surveillance guidelines after removal of colorectal adenomatous polyps Gut 51 2002 v6 v9
23. F.L. Greene, D.L. Page, I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
24. Wong CKH, Lam CLK, Poon JTC, et al. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective. J Eval Clin Pract. In press. DOI: 10.1111/j.1365-2753.2011.01776.x.
25. K. Webster, D. Cella, K. Yost The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation Health Qual Life Outcomes 1 2003 79
26. W.L. Ward, E.A. Hahn, F. Mo Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Qual Life Res 8 1999 181 195 (Pubitemid 29367288)
27. E.A. Hahn, D. Rao, D. Cella Comparability of interview- and self-administration of the Functional Assessment of Cancer Therapy-General (FACT-G) in English- and Spanish-speaking ambulatory cancer patients Med Care 46 2008 423 431
28. S.M. McGhee, J. Brazier, C.L.K. Lam Quality adjusted life years: population-specific measurement of the quality component Hong Kong Med J 17 Suppl 6 2011 S17 S21
29. E.T.P. Lam, C.C.K. Lam, C.L. Lai Health-related quality of life of Southern Chinese with chronic hepatitis B infection Health Qual Life Outcomes 7 2009 52
30. D.C. Montgomery, E.A. Peck, G.G. Vining Diagnostics for Leverage and Influence: Introduction to Linear Regression Analysis (4th ed.) 2006 Wiley-Interscience Hoboken, NJ
31. A.S. Pickard, J.W. Shaw, H.W. Lin A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Value Health 12 Suppl. 2009 977 988
32. Y.B. Cheung, J. Thumboo, F. Gao Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index Value Health 12 2009 371 376
33. L. McKenzie, M. van der Pol Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data Value Health 12 2009 167 171
34. S.J. Walters, J.E. Brazier Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D Qual Life Res 14 2005 1523 1532 (Pubitemid 40848233)
35. M. Versteegh, D.L. Rowen, J.E. Brazier Mapping onto EQ-5D for patients in poor health Health Qual Life Outcomes 8 2010 141
36. D.L. Rowen, J.E. Brazier, J. Roberts Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 7 2009 27
37. N. Payakachat, K. Summers, A. Pleil Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration Qual Life Res 18 2009 801 813
38. F. Xie, E.M. Pullenayegum, S.C. Li Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index Value Health 13 2010 873 878
39. P.W. Sullivan, V. Ghushchyan Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample Med Decis Making 26 2006 401 409 (Pubitemid 44050844)
40. I.C. Huang, C. Frangakis, M.J. Atkinson Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease Health Serv Res 43 2008 327 339 (Pubitemid 351601519)
41. J. Brazier, J. Roberts, A. Tsuchiya A comparison of the EQ-5D and SF-6D across seven patient groups Health Econ 13 2004 873 884 (Pubitemid 39264234)
42. A.M. Gray, O. Rivero-Arias, P.M. Clarke Estimating the association between SF-12 responses and EQ-5D utility values by response mapping Med Decis Making 26 2006 18 29 (Pubitemid 43134124)
43. Q.A. Le, J.N. Doctor Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample Med Care 49 2011 451 460